Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 8, 2005Journal of Cellular BiochemistryOpen Access

Prospects: Histone deacetylase inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

MDMilos DokmanovicUnited States Food and Drug AdministrationPMPaul A. MarksScripps Research Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dokmanovic et al. (2005) studied this question.

synapsesocial.com/papers/6a6bd90c26cff2e2f6f48723https://doi.org/10.1002/jcb.20532
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Physiological functions of thioredoxin and thioredoxin reductase2000 · 2,553 citations
  2. 2Histone-Deacetylase Inhibitors for the Treatment of Cancer2004 · 152 citations
  3. 3Histone Deacetylase Inhibitors in Cancer Therapy2003 · 158 citations
  4. 4Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors2005 · 508 citations
  5. 5CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS2004 · 603 citations